Sweden· SE-20190829000054

Raloxifen Ebb 60 mg Filmdragerad tablett

A raloxifene product containing raloxifen, registered in Sweden by Ebb Medical AB. The same ATC class is registered in 19 of our 19 countries.

ATC G03XC01

Checked against Swedish Medical Products Agency (Sweden) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about raloxifenAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Raloxifene is registered in 19 of 19 countries.

Countries holding a registration under ATC G03XC01 (raloxifene), each read from that country’s own register.

This record: Sweden, from Swedish Medical Products Agency (Sweden)
11 of them publish a price we can compare per daily dose

Search raloxifene products by name

Raloxifene · ATC G03XC01

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of raloxifene costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.44 in France to $1.28 in Switzerland — a ×2.9 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Raloxifene · price per daily dose (60 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.28
ES Spain$0.84
IT Italy$0.70
FR France$0.44

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)

Active substance: Raloxifen
Manufacturer: Ebb Medical AB
Country: Sweden (SE)
ATC code: G03XC01
ATC class: Raloxifene
Defined daily dose: 60 mg, O
Reimbursed: Not published by this register
Source register: Swedish Medical Products Agency (Sweden)
Last checked: October 1, 2026

Packs & prices · 1

se_varunummer
20190829000054

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

183 interactions on record for raloxifene.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check raloxifene against other medicines How interaction checks work

Raloxifene · interactions on record

183 records

8 severe
12 moderate
6 minor
157 info

Most severe, free to view

Tranexamic acidB02AA02severe
BexaroteneL01XF03severe
CarfilzomibL01XG02severe
BexarotenL01XX25severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Raloxifene in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All raloxifene products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Austria · Raloxifen Stada
Cyprus · Ostiral
Germany · Raloxifen Al, Raloxifen-Hcl Hexal
Spain · Raloxifeno Aurovitas, Raloxifeno Cinfamed
France · Raloxifene Arrow, Raloxifene Biogaran
United Kingdom (Northern Ireland) · Evirex, Ostiral
Greece · Ostiral
Hungary · Clastellos, Raloxibone
Iceland · Evista, Optruma
Italy · Raloxifene Sandoz
Liechtenstein · Evista, Optruma
Netherlands · Raloxifeenhydrochloride Brillpharma, Raloxifene Hydrochloride Aurobindo
Norway · Evista, Optruma
Portugal · Raloxifeno Ciclum, Raloxifeno Exeltis
Romania · Raloxifen Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fb085913-82f1-4d66-bafd-df066c41d411
GET /v1/drugs/fb085913-82f1-4d66-bafd-df066c41d411?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20190829000054",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190829000054",
  "product_doc_link": "https://docetp.mpa.se/LMF/Raloxifen%20Ebb%2060%20mg%20film-coated%20tablet%20PT%20PL_09001bee8095e37c.pdf"
}

API reference MCP server Plans

See everything about raloxifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console